ALMR
Alamar Biosciences, Inc.Company Information
- Company Name
- Alamar Biosciences, Inc.
- CIK
- CIK0002104204
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ALMR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3826
- SIC Description
- Laboratory Analytical Instruments
- Ticker
- ALMR
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-04-20
- Last sale
- —
- Shares purchased (TTM)
- 470,588
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 22,013,391
- Shares outstanding
- 58,665,055
- Ownership
- 37.52%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -15.78%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 133 | 65 | ||||||
| Short Term Investments | 117 | - | ||||||
| Accounts Receivable Net Current | 20 | 20 | ||||||
| Inventory Net | 45 | 40 | ||||||
| Prepaid Expense And Other Assets Current | 16 | 17 | ||||||
| Assets Current | 331 | 141 | ||||||
| Restricted Cash | 6 | 5 | ||||||
| Property Plant And Equipment Net | 13 | 10 | ||||||
| Operating Lease Right Of Use Asset | 36 | 26 | ||||||
| Capitalized Computer Software Net | 2 | 2 | ||||||
| Other Assets Noncurrent | 3 | 2 | ||||||
| Assets | 391 | 186 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 14 | 6 | ||||||
| Accrued Liabilities And Other Liabilities | 12 | 17 | ||||||
| Operating Lease Liability Current | 2 | 2 | ||||||
| Liabilities Current | 28 | 24 | ||||||
| Operating Lease Liability Noncurrent | 39 | 29 | ||||||
| Convertible Debt | - | 65 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | ||||||
| Liabilities | 78 | 130 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | 235 | ||||||
Stockholders Equity | ||||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital | 516 | 12 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -203 | -190 | ||||||
| Stockholders Equity | 313 | -178 | ||||||
| Liabilities And Stockholders Equity | 391 | 186 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAlamar Biosciences, Inc. (ALMR) — SEC Financial Statements & Analysis
Alamar Biosciences, Inc. (ALMR) is a laboratory analytical instruments company, incorporated in DE. Alamar Biosciences, Inc. trades on Nasdaq as: ALMR. Alamar Biosciences, Inc. (ALMR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Alamar Biosciences, Inc. carries a market cap of $1.59B, a P/B ratio of 5.08x, and an enterprise value of $1.46B. On the balance sheet, it maintains a current ratio of 11.85x, a quick ratio of 9.67x, working capital of $303.42M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.2, and net debt of $-132.97M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.59B
- P/B TTM
- 5.08x
- Debt To Equity
- 0.25x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Alamar Biosciences, Inc. in?
Alamar Biosciences, Inc. (ALMR) operates in the Laboratory Analytical Instruments industry.
What exchange does ALMR trade on?
Alamar Biosciences, Inc. (ALMR) trades on the Nasdaq.
Where is Alamar Biosciences, Inc. incorporated?
Alamar Biosciences, Inc. is incorporated in DE.
When was Alamar Biosciences, Inc. (ALMR)'s most recent SEC filing?
Alamar Biosciences, Inc. (ALMR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is ALMR's market cap?
Alamar Biosciences, Inc. (ALMR) has a market capitalization of $1.59B as of 2026-06-30.